FINWIRES · TerminalLIVE
FINWIRES

Primaris REIT Price Target Raised to $25 at CIBC

By

CIBC Capital Markets raised its price target on Primaris REIT (PMZ-UN.TO) to C$25 from C$22.

Analyst Tal Woolley maintained an Outperformer rating on shares of the Canadian shopping center-focused real estate company.

"We believe the outlook for PMZ can continue to improve in a Canadian retail environment with a lack of traditional department store anchor tenants," Woolley said in a note to clients.

"We also expect PMZ to soon offer another positive leasing update on its 1.3 million square feet of vacant anchor space," the analyst said.

CIBC's estimate of the company's return on invested capital average 7.4% over the next two years. That's "well ahead of the balance of our REIT coverage (averaging 5.8%), delivering higher returns needed for the higher operating risk with enclosed mall assets (with its discretionary spending exposure and higher capital intensity)," Woolley said.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Research

Craig Hallum Downgrades Apogee Therapeutics to Hold From Buy, $135.11 Price Target

Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $122.86, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $132.63, Change: $+42.25, Percent Change: +46.75%

$APGE
Research

Citigroup Downgrades Apogee Therapeutics to Neutral From Buy, Price Target is $135

Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $119.07, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $132.65, Change: $+42.27, Percent Change: +46.76%

$APGE
Research

Update: Seaport Global Upgrades BWX Technologies to Buy From Neutral, Price Target is $245

(Updates with the analyst's commentary.)Seaport Global upgraded BWX Technologies (BWXT) to buy from neutral, citing the company's acquisition of Precision Components Group after a "strong" fiscal Q1.PCG 2025 revenue was about $125 million and it paid about $200 million for the firm, the brokerage said, citing BWX management.PCG is an authorized nuclear component manufacturer and certified for aerospace and defense quality-management, Seaport said.BWX Technologies has an average rating of overweight and mean price target of $240.17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $212.56, Change: $+7.16, Percent Change: +3.49%

$BWXT